InspireMD (NSPR) EBIT Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 322,004.00 |
| Sep 30, 2025 | -29,330.00 |
| Jun 30, 2025 | 4,924.00 |
| Mar 31, 2025 | -55,405.00 |
| Dec 31, 2024 | 114,153.00 |
| Sep 30, 2024 | -25,484.00 |
| Jun 30, 2024 | -31,376.00 |
| Mar 31, 2024 | 26,355.00 |
| Dec 31, 2023 | -6,144.00 |
| Sep 30, 2023 | -10,506.00 |
| Jun 30, 2023 | -17,546.00 |
| Mar 31, 2023 | -15,965.00 |
| Dec 31, 2022 | -30,735.00 |
| Sep 30, 2022 | -3,176.00 |
| Jun 30, 2022 | 5,269.00 |
| Mar 31, 2022 | 4,329.00 |
| Dec 31, 2021 | 36,546.00 |
| Sep 30, 2021 | -154.00 |
| Jun 30, 2021 | -437.00 |
| Mar 31, 2021 | 3,114.00 |
| Dec 31, 2020 | -184,716.00 |
| Sep 30, 2020 | 31,574.00 |
| Jun 30, 2020 | -25,986.00 |
| Mar 31, 2019 | -38,074.00 |
| Sep 30, 2018 | -703.00 |
| Jun 30, 2018 | 13,414.00 |
| Mar 31, 2018 | 1,814.00 |
| Dec 31, 2017 | 14,967.00 |
| Sep 30, 2017 | 35,421.00 |
| Mar 31, 2017 | -14,780.00 |
| Dec 31, 2016 | -1,277.00 |
| Sep 30, 2016 | -26,658.00 |
| Jun 30, 2016 | -11,819.00 |
| Mar 31, 2016 | -29,117.00 |
| Dec 31, 2015 | -34,387.00 |
| Sep 30, 2015 | -48,109.00 |
| Jun 30, 2015 | -44,572.00 |